Guardant Health
GH
#1508
Rank
C$19.00 B
Marketcap
C$146.35
Share price
3.79%
Change (1 day)
184.42%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$2.25 Billion

According to Guardant Health 's latest financial reports the company's total liabilities are C$2.25 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$2.33 B8.03%
2023-12-31C$2.15 B2.66%
2022-12-31C$2.10 B5.81%
2021-12-31C$1.98 B70.13%
2020-12-31C$1.16 B680.89%
2019-12-31C$0.14 B75.85%
2018-12-31C$85.07 M97.09%
2017-12-31C$43.16 M-12.88%
2016-12-31C$49.54 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Natera
NTRA
C$0.78 B-65.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
C$1.74 B-22.79%๐Ÿ‡บ๐Ÿ‡ธ USA